Citadel Advisors
REVH

Citadel Advisors’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

Citadel Advisors’s Portfolio REVH Stock Details REVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,702,326
Closed -$26.6M – 15914
2022
Q3 		$26.6M Sell
2,702,326
-1,163
-0% -$11.4K 0.01% 1606
2022
Q2 		$26.4M Buy
2,703,489
+53,434
+2% +$523K 0.01% 1577
2022
Q1 		$26M Buy
2,650,055
+249,358
+10% +$2.43M 0.01% 1699
2021
Q4 		$23.3M Buy
2,400,697
+989,557
+70% +$9.66M ﹤0.01% 1852
2021
Q3 		$13.7M Buy
1,411,140
+405,933
+40% +$3.95M ﹤0.01% 2564
2021
Q2 		$9.87M Buy
+1,005,207
New +$9.9M ﹤0.01% 3095

Citadel Advisors's REVH Position: Q4 2022 in Review

Citadel Advisors sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 2,702,326 shares — an estimated $26.6M sold.

Citadel Advisors first reported a position in REVH in Q2 2021 and held it in 6 quarters. The position peaked at $26.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

  • Citadel Advisors reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 2,702,326 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $26.6M.
  • Citadel Advisors first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • Citadel Advisors's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $26.6M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.